SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0001193125-21-041686
Filing Date
2021-02-12
Accepted
2021-02-12 16:32:53
Documents
1
Group Members
CHART WESTCOTTIKARIAN HEALTHCARE FUND GP, L.P.IKARIAN HEALTHCARE MASTER FUND, L.P.NEIL SHAHRESTANI

Document Format Files

Seq Description Document Type Size
1 SC 13G/A d59359dsc13ga.htm SC 13G/A 116607
  Complete submission text file 0001193125-21-041686.txt   118493
Mailing Address 53 FRONTAGE ROAD SUITE 220 HAMPTON NJ 08827
Business Address 53 FRONTAGE ROAD SUITE 220 HAMPTON NJ 08827 908-200-7500
Celldex Therapeutics, Inc. (Subject) CIK: 0000744218 (see all company filings)

IRS No.: 133191702 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A | Act: 34 | File No.: 005-37761 | Film No.: 21628261
SIC: 2835 In Vitro & In Vivo Diagnostic Substances

Mailing Address 100 CRESCENT COURT SUITE 1620 DALLAS TX 75201
Business Address 100 CRESCENT COURT SUITE 1620 DALLAS TX 75201 214-364-2883
Ikarian Capital, LLC (Filed by) CIK: 0001778253 (see all company filings)

IRS No.: 473466768 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A